[
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) Rises Higher Than Market: Key Facts",
    "summary": "Johnson & Johnson (JNJ) closed the most recent trading day at $188.64, moving +1.43% from the previous trading session.",
    "url": "https://finnhub.io/api/news?id=4ca3a95050c812e65e36b5215ea59c0930af4df1115c383eaca47eeca667e6da",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759527902,
      "headline": "Johnson & Johnson (JNJ) Rises Higher Than Market: Key Facts",
      "id": 136980631,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (JNJ) closed the most recent trading day at $188.64, moving +1.43% from the previous trading session.",
      "url": "https://finnhub.io/api/news?id=4ca3a95050c812e65e36b5215ea59c0930af4df1115c383eaca47eeca667e6da"
    }
  },
  {
    "ts": null,
    "headline": "Stocks to Watch Recap: Apple, Applied Materials, Chevron, Broadcom",
    "summary": "↗️ Apple (AAPL): Shares in the tech giant are trading near their all-time high from last December. Strong demand for new iPhone 17s have pushed Apple stock higher in recent weeks. The shares rose 0.3% Friday.",
    "url": "https://finnhub.io/api/news?id=8d78417345de272e8576fccf6f00074e6c96d1d81679226f7bd6a452596c4900",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759525823,
      "headline": "Stocks to Watch Recap: Apple, Applied Materials, Chevron, Broadcom",
      "id": 136980452,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "↗️ Apple (AAPL): Shares in the tech giant are trading near their all-time high from last December. Strong demand for new iPhone 17s have pushed Apple stock higher in recent weeks. The shares rose 0.3% Friday.",
      "url": "https://finnhub.io/api/news?id=8d78417345de272e8576fccf6f00074e6c96d1d81679226f7bd6a452596c4900"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Gain Late Afternoon",
    "summary": "Health care stocks were higher late Friday afternoon, with the NYSE Health Care Index and the Health",
    "url": "https://finnhub.io/api/news?id=07fb2bb00f7c61b8f617f85bf63b6dae930a806ccb2320abed4595f9bd85341e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759520616,
      "headline": "Sector Update: Health Care Stocks Gain Late Afternoon",
      "id": 136967624,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Health care stocks were higher late Friday afternoon, with the NYSE Health Care Index and the Health",
      "url": "https://finnhub.io/api/news?id=07fb2bb00f7c61b8f617f85bf63b6dae930a806ccb2320abed4595f9bd85341e"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Stock Climbs As Wells Fargo Boosts Rating And Price Target",
    "summary": "Johnson & Johnson Gets Wells Fargo Upgrade, Sends Shares Higher",
    "url": "https://finnhub.io/api/news?id=29d9611246a817ccf7bcb4de9105226343b5306085db7ae8d65c7e3fb4ec2370",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759519051,
      "headline": "Johnson & Johnson Stock Climbs As Wells Fargo Boosts Rating And Price Target",
      "id": 136980634,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson Gets Wells Fargo Upgrade, Sends Shares Higher",
      "url": "https://finnhub.io/api/news?id=29d9611246a817ccf7bcb4de9105226343b5306085db7ae8d65c7e3fb4ec2370"
    }
  },
  {
    "ts": null,
    "headline": "B of A Securities Maintains Johnson & Johnson (JNJ) Neutral Recommendation",
    "summary": "B of A Securities Maintains Johnson & Johnson (JNJ) Neutral Recommendation",
    "url": "https://finnhub.io/api/news?id=0be39cde3efb05af4ab78cff9e7352f03ce86b0d027a3c127bea36739ba46533",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759517053,
      "headline": "B of A Securities Maintains Johnson & Johnson (JNJ) Neutral Recommendation",
      "id": 136966718,
      "image": "",
      "related": "JNJ",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=0be39cde3efb05af4ab78cff9e7352f03ce86b0d027a3c127bea36739ba46533"
    }
  },
  {
    "ts": null,
    "headline": "Dow touches above 47,000, while J&J stock receives upgrade",
    "summary": "Yahoo Finance host Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute, including the Dow Jones Industrial Average (^DJI) touching above 47,000 for the first ever in Friday's trading, Johnson & Johnson (JNJ) receiving an upgrade by Wells Fargo analysts, and PayPal (PYPL) being hit with a downgrade. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
    "url": "https://finnhub.io/api/news?id=57431b29b27ede9843d076637b96a3eefcac8d0ee82886f813bbc3cf9b45c9e0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759514822,
      "headline": "Dow touches above 47,000, while J&J stock receives upgrade",
      "id": 136980635,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Yahoo Finance host Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute, including the Dow Jones Industrial Average (^DJI) touching above 47,000 for the first ever in Friday's trading, Johnson & Johnson (JNJ) receiving an upgrade by Wells Fargo analysts, and PayPal (PYPL) being hit with a downgrade. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
      "url": "https://finnhub.io/api/news?id=57431b29b27ede9843d076637b96a3eefcac8d0ee82886f813bbc3cf9b45c9e0"
    }
  },
  {
    "ts": null,
    "headline": "Wells Fargo sees ‘room to run’ for Johnson & Johnson, highlights pharma upside",
    "summary": "Investing.com -- Wells Fargo upgraded Johnson & Johnson to Overweight from Equal Weight in a note on Friday, citing attractive valuation and greater confidence in the company’s pharmaceutical growth outlook.",
    "url": "https://finnhub.io/api/news?id=51274e954c04d9e4e239d461457f22e5947f1e1a35bb0cb700647331f0cc2c69",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759500984,
      "headline": "Wells Fargo sees ‘room to run’ for Johnson & Johnson, highlights pharma upside",
      "id": 136965078,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Investing.com -- Wells Fargo upgraded Johnson & Johnson to Overweight from Equal Weight in a note on Friday, citing attractive valuation and greater confidence in the company’s pharmaceutical growth outlook.",
      "url": "https://finnhub.io/api/news?id=51274e954c04d9e4e239d461457f22e5947f1e1a35bb0cb700647331f0cc2c69"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth, Travelers share gains lead Dow's 325-point jump",
    "summary": "UnitedHealth, Travelers share gains lead Dow's 325-point jump",
    "url": "https://finnhub.io/api/news?id=a4f9257a3b98b6fa4392ff532f5eac3d376e2ec73227e57a0e2e866e8b6be81c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759499460,
      "headline": "UnitedHealth, Travelers share gains lead Dow's 325-point jump",
      "id": 136995718,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "UnitedHealth, Travelers share gains lead Dow's 325-point jump",
      "url": "https://finnhub.io/api/news?id=a4f9257a3b98b6fa4392ff532f5eac3d376e2ec73227e57a0e2e866e8b6be81c"
    }
  },
  {
    "ts": null,
    "headline": "Apple downgraded, Alibaba upgraded: Wall Street's top analyst calls",
    "summary": "Apple downgraded, Alibaba upgraded: Wall Street's top analyst calls",
    "url": "https://finnhub.io/api/news?id=f79967b041a7418231d9fcbd8ace4b4ff3522821280ab055bfee59c2a61ebe52",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759498978,
      "headline": "Apple downgraded, Alibaba upgraded: Wall Street's top analyst calls",
      "id": 136964334,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Apple downgraded, Alibaba upgraded: Wall Street's top analyst calls",
      "url": "https://finnhub.io/api/news?id=f79967b041a7418231d9fcbd8ace4b4ff3522821280ab055bfee59c2a61ebe52"
    }
  },
  {
    "ts": null,
    "headline": "ImmunityBio: A Small Bet Is Warranted",
    "summary": "ImmunityBio offers significant upside despite ongoing dilution and cash burn concerns. Click here to read an analysis of IBRX stock now.",
    "url": "https://finnhub.io/api/news?id=79b8a7a844b648e07083bde5435ae809c7946248f4d405f7e408dd5db381d5d6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759497864,
      "headline": "ImmunityBio: A Small Bet Is Warranted",
      "id": 136966013,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2167417147/image_2167417147.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "ImmunityBio offers significant upside despite ongoing dilution and cash burn concerns. Click here to read an analysis of IBRX stock now.",
      "url": "https://finnhub.io/api/news?id=79b8a7a844b648e07083bde5435ae809c7946248f4d405f7e408dd5db381d5d6"
    }
  },
  {
    "ts": null,
    "headline": "Wells Fargo Upgrades Johnson & Johnson (JNJ)",
    "summary": "Wells Fargo Upgrades Johnson & Johnson (JNJ)",
    "url": "https://finnhub.io/api/news?id=4d9771d8fc1585d0c37a7564ac5522fc4875fa20e7513fc8bdc5e73ca78ea33c",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759493002,
      "headline": "Wells Fargo Upgrades Johnson & Johnson (JNJ)",
      "id": 136963960,
      "image": "",
      "related": "JNJ",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=4d9771d8fc1585d0c37a7564ac5522fc4875fa20e7513fc8bdc5e73ca78ea33c"
    }
  },
  {
    "ts": null,
    "headline": "How BeOne Medicines, An IBD 50 Stock, Is Taking On Big Names In Cancer Treatment",
    "summary": "As the former BeiGene gears up to battle AbbVie and J&J, shares of the new BeOne Medicines haven't been this high in four years.",
    "url": "https://finnhub.io/api/news?id=542f2b1b75b8988cf9ad4aa311e83a32204312a65c8d207c95eda8dff57335b3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759492844,
      "headline": "How BeOne Medicines, An IBD 50 Stock, Is Taking On Big Names In Cancer Treatment",
      "id": 136963844,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "As the former BeiGene gears up to battle AbbVie and J&J, shares of the new BeOne Medicines haven't been this high in four years.",
      "url": "https://finnhub.io/api/news?id=542f2b1b75b8988cf9ad4aa311e83a32204312a65c8d207c95eda8dff57335b3"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth, Caterpillar share gains lead Dow's 467-point rally",
    "summary": "UnitedHealth, Caterpillar share gains lead Dow's 467-point rally",
    "url": "https://finnhub.io/api/news?id=76731e754d1d129a05ecf6ba44fb10b7424845ae5962278e9d158f712c0f60d8",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759488360,
      "headline": "UnitedHealth, Caterpillar share gains lead Dow's 467-point rally",
      "id": 136995719,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "UnitedHealth, Caterpillar share gains lead Dow's 467-point rally",
      "url": "https://finnhub.io/api/news?id=76731e754d1d129a05ecf6ba44fb10b7424845ae5962278e9d158f712c0f60d8"
    }
  },
  {
    "ts": null,
    "headline": "Barclays Maintains a Hold Rating on Johnson & Johnson (JNJ) With a $176 PT",
    "summary": "Johnson & Johnson (NYSE:JNJ) is one of the best medical stocks to buy now. In a report released on September 30, Matt Miksic from Barclays maintained a Hold rating on Johnson & Johnson (NYSE:JNJ) and set a price target of $176.00. The rating update came after Johnson & Johnson (NYSE:JNJ) reported on September 29 the […]",
    "url": "https://finnhub.io/api/news?id=82d3771ffc7a21dc880ec0ede64ac364a14bb8bde3baacf73e9a84a93014ef14",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759487274,
      "headline": "Barclays Maintains a Hold Rating on Johnson & Johnson (JNJ) With a $176 PT",
      "id": 136963178,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) is one of the best medical stocks to buy now. In a report released on September 30, Matt Miksic from Barclays maintained a Hold rating on Johnson & Johnson (NYSE:JNJ) and set a price target of $176.00. The rating update came after Johnson & Johnson (NYSE:JNJ) reported on September 29 the […]",
      "url": "https://finnhub.io/api/news?id=82d3771ffc7a21dc880ec0ede64ac364a14bb8bde3baacf73e9a84a93014ef14"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb, Takeda, Astex Join AI Consortium to Train OpenFold3 for Accelerated Drug Discovery",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the most undervalued stocks to buy and hold for 5 years. On October 1, Bristol-Myers Squibb, Takeda Pharmaceuticals (NYSE:TAK), and Astex Pharmaceuticals agreed to collaborate and pool proprietary data for drug discovery using an AI model. These companies are joining an existing consortium that already includes AbbVie Inc. […]",
    "url": "https://finnhub.io/api/news?id=7d4864be8561163f177ed8bce88625ff4dcdd85c5c7ff67f53b7d4b96cb712e4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759483994,
      "headline": "Bristol-Myers Squibb, Takeda, Astex Join AI Consortium to Train OpenFold3 for Accelerated Drug Discovery",
      "id": 136963179,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the most undervalued stocks to buy and hold for 5 years. On October 1, Bristol-Myers Squibb, Takeda Pharmaceuticals (NYSE:TAK), and Astex Pharmaceuticals agreed to collaborate and pool proprietary data for drug discovery using an AI model. These companies are joining an existing consortium that already includes AbbVie Inc. […]",
      "url": "https://finnhub.io/api/news?id=7d4864be8561163f177ed8bce88625ff4dcdd85c5c7ff67f53b7d4b96cb712e4"
    }
  }
]